Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Announces Closing of Second Tranche of Equity Private Placement Financing

February 28, 2024


BURLINGTON, Ontario – February 23, 2024 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it has closed on $200,000 in a second tranche of its previously announced equity private placement financing (the “Financing”), bringing the total amount raised to...

Rapid Dose Announces Closing of First Tranche of Equity Private Placement Financing

February 20, 2024


BURLINGTON, Ontario – February 16, 2024 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it has closed on $1,100,000 in a first tranche of its previously announced equity private placement financing (the “Financing”) which contemplated up to $7,000,000 of...

RAPID DOSE THERAPEUTICS ANNOUNCES A NEW BOARD MEMBER

February 8, 2024


Burlington, Ontario – February 7, 2024 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) trading on the Canadian Securities Exchange (“CSE”) under the symbol MKT:DOSE announces the appointment of Angela O’Leary to the Board of Directors. Mark Upsdell, CEO of RDT said ““We are...

Rapid Dose Announces Proposed Equity Private Placement Financing

January 20, 2024


BURLINGTON, Ontario – January 19, 2024 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete an equity private placement financing (the “Financing”) for up to $7,000,000 of gross proceeds, consisting of up to 41,176,470 units (the...

Rapid Dose Closes Fourth Tranche of Private Placement Financing and Announces Proposed Debt Settlement

December 22, 2023


BURLINGTON, Ontario – December 22, 2023 Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has closed on $855,000 in a fourth tranche of its previously announced private placement financing (the “Financing”) bringing the total amount invested to...

Rapid Dose Therapeutics Corp. Provides Update on Private Placement

December 6, 2023


BURLINGTON, Ontario – December 6, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated November 14, 2023 announcing a third tranche closing of $500,000, thereby bringing the total amount invested to approximately $2,300,000,...

Rapid Dose Therapeutics Corp. Engages European Consulting Firm

November 22, 2023


BURLINGTON, Ontario – November 22, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has retained Profinnotiv AG (the “Consultant”) to provide the Company with investor and public relations services in the European market, including brand...

Rapid Dose Therapeutics Corp. Closes Third Tranche of Private Placement Financing

November 14, 2023


BURLINGTON, Ontario – November 14, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has closed on $500,000 in a third tranche of its previously announced private placement financing (the “Financing”) bringing the total amount invested...

Rapid Dose Therapeutics Corp. Provides Update on Private Placement

October 25, 2023


BURLINGTON, Ontario – October 24, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated September 22, 2023 announcing a second tranche closing of approximately $300,000, thereby bringing the total amount invested to approximately...

‘Game changer’ A revolution in vaccines, medication and drugs happening in Burlington

October 19, 2023


As we celebrate Small Business Week, Effie J. Triantafilopoulos, MPP for Oakville North -Burlington, toured the Rapid Dose Therapeutics facility in Burlington on Oct. 12 to discuss their innovative Oral Thin Film (OTF) delivery platform and highlight the company’s recent achievements. “You’ve got seniors who...

1 2 3 4 5 6 7 8 9 10 11 12 15